SEC Form 4 · accession 0001567619-18-001350
RESMED INC · RMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James Hollingshead
Officer — President, Americas
Period of report
Aug 15, 2018
Accepted (ET)
Aug 17, 2018 · 12:50 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000943819
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| ResMed Common StockF1 | Aug 15, 2018 | A | 12,160 | $0.00 | A | 71,823 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents performance-based restricted stock units granted on November 16, 2017. The shares were earned on August 15, 2018, when the compensation committee certified that the performance metrics were met.